Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with trypanosoma cruzi antigens

BACKGROUND: Benznidazole (Bz)-chemotherapy is recommended to prevent Chagas disease progression, despite its limited efficacy during chronic disease. However, the host mechanisms underlying these benefits still remain to be elucidated. METHODS: In this study, we have used short-term whole blood cult...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathler-Avelar, Renato, Vitelli-Avelar, Danielle Marquete, Elói-Santos, Silvana Maria, Gontijo, Eliane Dias, Teixeira-Carvalho, Andréa, Martins-Filho, Olindo Assis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519593/
https://www.ncbi.nlm.nih.gov/pubmed/22625224
http://dx.doi.org/10.1186/1471-2334-12-123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519593/
https://www.ncbi.nlm.nih.gov/pubmed/22625224
http://dx.doi.org/10.1186/1471-2334-12-123

Ejemplares similares